July 18, 2024

US Clinical Trials Market Size To Cross USD 39.62 Bn By 2032

The US clinical trials market size accounted for US$ 24.61 Bn in 2022 and is projected to reach around USD 39.62 Bn by 2032, growing at a CAGR of 4.88% from 2023 to 2032.

US Clinical Trials Market Size 2023 To 2032

Report Summary

The global US clinical trials market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the US clinical trials market across the globe.

A comprehensive estimate on the US clinical trials market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of US clinical trials during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2480

US Clinical Trials Market Report Scope

Report CoverageDetails
Market Size in 2022USD 24.61 Billion
Market Size by 2032USD 39.62 Billion
Growth Rate from 2023 to 2032CAGR of 4.88%
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Phase, By Study Design, By Indication

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized US clinical trials market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  US Liquid Biopsy Market Size To Cross USD 1,816.95 Mn By 2032

US Clinical Trials Market  Players

The report includes the profiles of key US clinical trials market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Parexel International Corp.
  • Charles River Laboratory
  • PRA Health Sciences
  • Wuxi AppTec
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Clinipace
  • Omnicare
  • Kendle
  • Chiltern

Market Segmentation

By Phase 

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design 

  • Interventional
  • Observational

By Indication

  • Oncology
  • Autoimmune
  • Pain Management
  • CNS Conditions
  • Obesity
  • Cardiovascular
  • Diabetes

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.


Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Clinical Trials Market 

5.1. COVID-19 Landscape: US Clinical Trials Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape List of Suppliers List of Buyers

Chapter 8. US Clinical Trials Market, By Phase

8.1. US Clinical Trials Market, by Phase, 2023-2032

8.1.1 Phase I Market Revenue and Forecast (2023-2032)

8.1.2. Phase II Market Revenue and Forecast (2023-2032)

8.1.3. Phase III Market Revenue and Forecast (2023-2032)

8.1.4. Phase IV Market Revenue and Forecast (2023-2032)

Chapter 9. US Clinical Trials Market, By Study Design

9.1. US Clinical Trials Market, by Study Design, 2023-2032

9.1.1. Interventional Market Revenue and Forecast (2023-2032)

9.1.2. Observational Market Revenue and Forecast (2023-2032)

Chapter 10. US Clinical Trials Market, By Indication 

10.1. US Clinical Trials Market, by Indication, 2023-2032

10.1.1. Oncology Market Revenue and Forecast (2023-2032)

10.1.2. Autoimmune Market Revenue and Forecast (2023-2032)

10.1.3. Pain Management Market Revenue and Forecast (2023-2032)

10.1.4. CNS Conditions Market Revenue and Forecast (2023-2032)

10.1.5. Obesity Market Revenue and Forecast (2023-2032)

10.1.6. Cardiovascular Market Revenue and Forecast (2023-2032)

10.1.7. Diabetes Market Revenue and Forecast (2023-2032)

Chapter 11. Global US Clinical Trials Market, Regional Estimates and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Phase (2023-2032)

11.1.2. Market Revenue and Forecast, by Study Design (2023-2032)

11.1.3. Market Revenue and Forecast, by Indication (2023-2032)

Chapter 12. Company Profiles

12.1. Parexel International Corp.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Charles River Laboratory

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. PRA Health Sciences

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Wuxi AppTec

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Eli Lilly and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Novo Nordisk A/S

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Clinipace

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Omnicare

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Kendle

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Chiltern

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333


Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com